056090 — CG MedTech Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for CG MedTech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	27,775	38,055	41,169	34,969	34,623
Cost of Revenue
Gross Profit	6,183	15,859	19,052	18,260	16,125
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	38,579	43,139	40,764	36,710	35,717
Operating Profit	-10,804	-5,084	405	-1,741	-1,094
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-12,108	-5,406	-18,421	1,387	12.9
Provision for Income Taxes
Net Income After Taxes	-12,283	-5,215	-18,808	1,306	-125
Minority Interest
Net Income Before Extraordinary Items
Net Income	-12,283	-4,970	-18,540	1,629	59.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-12,283	-4,970	-18,540	1,629	59.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-320	-49.7	-280	18.9	-0.436
Dividends per Share